chronic

Thrombocytopenia Investigation & Referral

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus. · BSH Guideline for the Investigation and Management of ITP 2020

Verified against3 documents

BSH Guideline for the Investigation and Management of ITP 2020 for the regimen, with the dose from Egyptian National Drug Formulary - Endocrine System Drugs 2024, Prednisolone monograph (printed pages 169-170): "Oral: Usual Initial doses: 5 to 60 mg/day given in a single daily dose or in 2 to 4 divided doses." and, for children, "Infants, Children, and Adolescents: Oral: initial: 0.1 to 2 mg/kg/day (4 to 60 mg/m2 BSA/day), in divided doses 1 to 4 times daily." The formulary states general ranges rather than an ITP regimen; the 1 mg/kg course is from the BSH guideline, which is not held in this corpus.
BSH Guideline for the Investigation and Management of ITP 2020
Thrombocytopenia - disease-level clinical article (thrombocytopenia-referral-clinical.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (4)

Patients are usually symptom-free above 50,000/uL platelets, while spontaneous bleeding is common below 20,000/uL [bleeding]
A bleeding history should cover petechiae, bleeding episodes, gum bleeding, and nosebleeds [bleeding · gum bleeding · nosebleed · petechiae]
Mouth purpura and visible blood in the urine deserve special attention as possible warnings of severe ITP-related bleeding [bleeding · blood in the urine · purpura · rash]
In pregnancy, headache, vision changes, abdominal pain, or a flu-like illness may suggest preeclampsia or HELLP syndrome [abdominal pain · headache]

Signs — what you find (4)

Typical bleeding signs are petechiae, purpura that is not raised, and bruising [bleeding · bruising · petechiae · purpura · rash]
Dry purpura is confined to the skin, while wet purpura involves the mucous membranes and signals higher bleeding risk [bleeding · purpura · rash]
An enlarged liver or spleen points toward lymphoma, chronic liver disease, or another blood disorder [hepatomegaly]
Enlarged lymph nodes can point to infection, autoimmune disease, lymphoma, or another malignancy [lymphadenopathy]

Tests (8)

Initial work-up includes a CBC, peripheral smear, HIV and hepatitis C testing, and a repeat CBC to rule out a lab error
Anemia accompanying thrombocytopenia raises suspicion for infection, DIC, sepsis, thrombotic microangiopathy, or an autoimmune disorder such as Felty syndrome
A high white count alongside low platelets suggests infection, malignancy, or chronic inflammation, while pancytopenia points to a myelodysplastic syndrome
Suspected autoimmune disease warrants antinuclear and antiphospholipid antibody testing
A bone marrow biopsy is needed when the cause stays unclear or a blood cancer is suspected
Normal or high megakaryocyte counts on marrow biopsy suggest increased platelet destruction, while reduced megakaryocytes with other low cell lines suggest aplastic anemia
In SLE, a severe drop or absence of marrow megakaryocytes can result from antibodies against the thrombopoietin receptor
Megaloblastic marrow changes point to B12, folate, or copper deficiency, while dysplastic cell features point to myelodysplastic syndrome

If not this — what else fits (3)

Pseudothrombocytopenia is a lab artifact from in-vitro platelet clumping caused by EDTA-dependent agglutinins, poor specimen anticoagulation, or glycoprotein IIb/IIIa inhibitors
Automated cell counters can mistake unusually large platelets for white blood cells, giving a falsely low platelet count
A functional platelet defect from uremia or liver disease can be mistaken for true thrombocytopenia despite a normal platelet count

SourceStatPearls "Thrombocytopenia" - disease-level clinical article

Presentation findings are traced to the source above.

PREDNISOLONE

1st line

Strength5 mg

Formoral.solid

Adult dose and duration

1 mg/kg once daily in the morning for 2-4 weeks, then taper under specialist haematology guidance x 2-4 weeks initial course

Paediatric dose

1-2 mg/kg/day [child max 60 mg]

(1-2 mg/kg once daily (max 60 mg) for 14 days under pediatric haematologist guidance)

Dose by weight
3kg	3-6 mg/day
4kg	4-8 mg/day
5kg	5-10 mg/day
6kg	6-12 mg/day
7kg	7-14 mg/day
8kg	8-16 mg/day
9kg	9-18 mg/day
10kg	10-20 mg/day
11kg	11-22 mg/day
12kg	12-24 mg/day
13kg	13-26 mg/day
14kg	14-28 mg/day
15kg	15-30 mg/day
16kg	16-32 mg/day
17kg	17-34 mg/day
18kg	18-36 mg/day
19kg	19-38 mg/day
20kg	20-40 mg/day
21kg	21-42 mg/day
22kg	22-44 mg/day
23kg	23-46 mg/day
24kg	24-48 mg/day
25kg	25-50 mg/day
26kg	26-52 mg/day
27kg	27-54 mg/day
28kg	28-56 mg/day
29kg	29-58 mg/day
30kg	30-60 mg/day
31kg	31-60 mg/day (upper capped)
32kg	32-60 mg/day (upper capped)
33kg	33-60 mg/day (upper capped)
34kg	34-60 mg/day (upper capped)
35kg	35-60 mg/day (upper capped)
36kg	36-60 mg/day (upper capped)
37kg	37-60 mg/day (upper capped)
38kg	38-60 mg/day (upper capped)
39kg	39-60 mg/day (upper capped)
40kg	40-60 mg/day (upper capped)
41kg	41-60 mg/day (upper capped)
42kg	42-60 mg/day (upper capped)
43kg	43-60 mg/day (upper capped)
44kg	44-60 mg/day (upper capped)
45kg	45-60 mg/day (upper capped)
46kg	46-60 mg/day (upper capped)
47kg	47-60 mg/day (upper capped)
48kg	48-60 mg/day (upper capped)
49kg	49-60 mg/day (upper capped)
50kg	50-60 mg/day (upper capped)

Dose source

Why

First-line initial therapy for acute symptomatic ITP with platelet count <30 x 10^9/L or mucosal bleeding

Cautions

URGENT HAEMATOLOGY REFERRAL IS MANDATORY for unexplained low platelets (<100 x 10^9/L).
Perform blood film immediately to exclude pseudothrombocytopenia (EDTA clumping), acute leukaemia, microangiopathic haemolytic anaemia (TTP/HUS), or aplastic anaemia.
AVOID NSAIDs, Aspirin, and IM injections.
Emergency admission is needed if there is active severe bleeding or platelets <10 x 10^9/L.

Egyptian brands

Egyptian brand	Manufacturer	Indicative price
HOSTACORTIN H 5MG 30 TAB.	SANOFI	12.00 EGP (0.40/unit)
PREDNISOLONE 5 MG 20 TABS.	ARAB DRUG COMPANY (ADCO)	24.00 EGP (1.20/unit)
PREDILONE 5MG 10 TAB. (25 STRIPS PACK)	KAHIRA	250.00 EGP (25.00/unit)
EPICOPRED 5 MG 30 ORODISPERSIBLE TABS.	EIPICO	69.00 EGP
PREDNISOLONE-EVA 5 MG 30 ORODISPERSIBLE TABS.	EVA PHARMA	79.50 EGP
DISPRELONE-OD 5 MG 30 ORODISPERSABLE TABS.	ANDALOUS PHARMA	84.00 EGP
SOLUPRED ORO 5 MG 30 ORODISPERSIBLE TABS.	SANOFI WINTHROP > SANOFI	84.00 EGP
ACETASEE 1% EYE DROPS (SUSP.) 5 ML? strength differs? different route - not oral solid	RAMEDA	7.50 EGP
PREDNIS 5MG/5ML SYRUP 100 ML? strength differs? different route - not oral solid	PHAROPHARMA	9.50 EGP

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line

Dose source

Thrombocytopenia - disease-level clinical article (thrombocytopenia-referral-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions

RED FLAG - Immediate (not routine) hematology consultation is required for life-threatening causes: TTP, HUS, HIT, aplastic anemia, leukemia, and other bone-marrow-failure conditions.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.